Related Experiment Video

Updated: May 12, 2026

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
09:06

Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease

Published on: June 9, 2018

Juvenile Huntington's disease: a population-based study using the General Practice Research Database

Ian Douglas1, Stephen Evans, Michael D Rawlins

  • 1Department of Epidemiology, London School of Hygiene and Tropical Medicine, University of London, London, UK.

BMJ Open
|April 6, 2013
PubMed

Insights

Juvenile Huntington's disease (HD) is extremely rare in the UK, with an estimated incidence of 0.70 per million patient-years. Current treatments lack evidence for safety and efficacy, necessitating urgent research.

Area of Science:

  • Neurology
  • Genetics
  • Epidemiology

Background:

  • Juvenile Huntington's disease (HD) is a rare, complex neurological disorder.
  • Population-based incidence and prevalence data for juvenile HD are lacking globally.
  • This study aimed to estimate juvenile HD frequency in the UK and review its pharmacological management.

Purpose of the Study:

  • To estimate the incidence and prevalence of juvenile Huntington's disease (HD) in the United Kingdom.
  • To analyze the range of pharmacological treatments utilized for juvenile HD management.
  • To highlight the need for evidence-based treatment strategies.

Main Methods:

  • Utilized the General Practice Research Database (1990-2010) for UK patient records.
  • Identified individuals under 21 with diagnosed Huntington's disease (HD).
  • Calculated minimum population-based estimates for incidence and prevalence.

Main Results:

  • Identified 12 incident and 21 prevalent cases of juvenile HD.
  • Minimum incidence estimated at 0.70 per million patient-years; minimum prevalence at 6.77 per million.
  • Commonly prescribed medications included antidepressants, hypnotics, antipsychotics, and motor abnormality treatments.

Conclusions:

  • Juvenile HD is exceptionally rare and complex in the UK.
  • Current clinical management lacks a formal evidence base for treatment efficacy and safety.
  • Urgent research into safe and effective therapies is required, potentially through multinational collaboration.
Abstract

More Related Videos

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System10:52

Efficient and Scalable Production of Full-length Human Huntingtin Variants in Mammalian Cells using a Transient Expression System

Published on: December 10, 2021

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering09:43

Databases to Efficiently Manage Medium Sized, Low Velocity, Multidimensional Data in Tissue Engineering

Published on: November 22, 2019

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Investigation of Disease Outbreaks01:23

Investigation of Disease Outbreaks

Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is: